Business Monitor International


Filter results

Pharmaceutical Reports

Showing 1-20 of 180
Sort By
World Pharmaceuticals Factbook 2014

World Pharmaceuticals Factbook 2014

Pub date:09 Sep 2014

The newly updated World Pharmaceuticals Fact Book 2014 is the must-have source of thousands of facts, figures and statistics for 72 pharmaceuticals markets worldwide! Now including analysis trends for 2009-2014 this reports looks at ...
$1,545.00
Read More...
Algeria Pharmaceuticals & Healthcare Report

Algeria Pharmaceuticals & Healthcare Report

Pub date:15 Aug 2014

BMI View:   The  Algerian government 's   aspirations to rebalance the pharmaceutical trade deficit and promot e local generic produc tion , whilst enhancing the country's competitiveness by stimulating the innovative biopharmaceutical industry as a st rategic ...
$1,295.00
Read More...
Angola Pharmaceuticals & Healthcare Report

Angola Pharmaceuticals & Healthcare Report

Pub date:18 Aug 2014

BMI View: Both government and foreign investment will see the Angolan healthcare sector continue to grow in the coming years mainly due the country ' s rich oil reserves attracting external revenues. Angola ' s ...
$1,295.00
Read More...
Argentina Pharmaceuticals & Healthcare Report

Argentina Pharmaceuticals & Healthcare Report

Pub date:22 Aug 2014

BMI View: The Argentine economy is still reeling from the January 2014 currency devaluation. Soaring inflation and stringent drug pricing controls will continue to discourage investment and erode the growth of the country's pharmaceutical market. More ...
$1,295.00
Read More...
Australia Pharmaceuticals & Healthcare Report

Australia Pharmaceuticals & Healthcare Report

Pub date:15 Aug 2014

BMI View:   Over 300 drug formulations listed on the Pharmaceutical Benefits Scheme (PBS) will be subject to price reduction from October 1 2014, following the first simplified price disclosure (SPD) cycle in Australia. As a result, the prices ...
$1,295.00
Read More...
Austria Pharmaceuticals & Healthcare Report

Austria Pharmaceuticals & Healthcare Report

Pub date:12 Sep 2014

BMI View:   BMI has upwardly revised its pharmaceutical and healthcare forecasts for Austria, reflecting the country's improving economic prospects and attractiveness of these sector s in particular. The United States Commerce department has listed Austria ...
$1,295.00
Read More...
Bahrain Pharmaceuticals & Healthcare Report

Bahrain Pharmaceuticals & Healthcare Report

Pub date:04 Sep 2014

BMI View:   Bahrain ' s pharmaceutical market ou tlook over the medium- and long- term remain bullish despite recent price cuts made to a v ariety of medicines across the country ,   contributing to only moderate ...
$1,295.00
Read More...
Bangladesh Pharmaceuticals & Healthcare Report

Bangladesh Pharmaceuticals & Healthcare Report

Pub date:12 Sep 2014

BMI View:   We consider Bangladesh 's commitment to another round of spending on the development of healthcare, information technology, infrastructure, energy production, education, agriculture and food security and transportation in fiscal year 2014/2015 as a sound ...
$1,295.00
Read More...
Belarus Pharmaceuticals & Healthcare Report

Belarus Pharmaceuticals & Healthcare Report

Pub date:24 Sep 2014

BMI View: The Belarusian economy is set to suffer a prolonged period of economic instability as a result of a decline in global potash prices and an escalating trade war with Russia. If Russo-Belarusian relations ...
$1,295.00
Read More...
Belgium Pharmaceuticals & Healthcare Report

Belgium Pharmaceuticals & Healthcare Report

Pub date:04 Sep 2014

BMI View:   Multinational firms find Belgium to be an attractive investment destination as a European hub for clinical trials, new drug development and niche research. Even though per capita spending on pharmaceuticals is relatively high, ...
$1,295.00
Read More...
Botswana Pharmaceuticals & Healthcare Report

Botswana Pharmaceuticals & Healthcare Report

Pub date:02 Sep 2014

BMI View:   We remain reasonably optimistic regarding the growth potential of the pharmaceutical and healthcare markets in Botswana, due to the government's efforts at improving healthcare and developing pharmaceutical production within the country. Risks to ...
$1,295.00
Read More...
Brazil Pharmaceuticals & Healthcare Report

Brazil Pharmaceuticals & Healthcare Report

Pub date:04 Sep 2014

BMI View:   Brazil's traditional commitment to healthcare, strong government support for the provision of medical services, promising private healthcare growth and the expanding middle-class mean that there are significant revenue-generating opportunities for drugmakers, medical device ...
$1,295.00
Read More...
Bulgaria Pharmaceuticals & Healthcare Report

Bulgaria Pharmaceuticals & Healthcare Report

Pub date:04 Sep 2014

BMI View:   The parlous situation of the NHIF and the inability of the Bulgarian parliament to agree on the interim state budget present considerable risks to our 2014 and 2015 forecasts. Bulgaria's positive economic outlook in 2014/15 will ...
$1,295.00
Read More...
Cambodia Pharmaceuticals & Healthcare Report

Cambodia Pharmaceuticals & Healthcare Report

Pub date:26 Sep 2014

BMI View: The current lack of investment in healthcare in Cambodia will continue to deter foreign pharmaceutical firms from entering the country .   Consequently, we highlight that Cambodia will remain one of the least attractive markets ...
$1,295.00
Read More...
Cameroon Pharmaceuticals & Healthcare Report

Cameroon Pharmaceuticals & Healthcare Report

Pub date:27 Aug 2014

BMI View:   A combination of the adoption of different mobile health innovations, health-targeted foreign aid inflows and sustained infrastructure investment will continue to create opportunities for health sector improvement in Cameroon over the medium term. ...
$1,295.00
Read More...
Canada Pharmaceuticals & Healthcare Report

Canada Pharmaceuticals & Healthcare Report

Pub date:02 Sep 2014

BMI View:   Canada   will continue to attract pharmaceutical companies to lau n ch innovative medicines due to the hospitable business environment, improving healthcare coverage and broader drug reimbursement lists.   The regulatory authority also encourages pharmaceutical ...
$1,295.00
Read More...
Central America Pharmaceuticals & Healthcare Report

Central America Pharmaceuticals & Healthcare Report

Pub date:11 Sep 2014

BMI View: Costa Rica and Panama will continue to outperfor m other Central American countries, namely El Salvador, Guatemala, Honduras, Nicaragua and Belize . The business-friendly environment, high per-capita medicine spending and strong consumer demand still ...
$1,295.00
Read More...
Chile Pharmaceuticals & Healthcare Report

Chile Pharmaceuticals & Healthcare Report

Pub date:23 Jun 2014

BMI View: Private healthcare insurance companies in Chile will face increasing risks due to the Isapres reform in terms of lower profits and challenges resulting from the separation of insurance and clinic management business units. ...
$1,295.00
Read More...
China Pharmaceuticals and Healthcare Report

China Pharmaceuticals and Healthcare Report

Pub date:04 Sep 2014

BMI View:  A more 'rational' use of pharmaceuticals through pharmacoeconomics, and a crackdown on illegal rebates and corruption in China's pharmaceutical market could hinder the sector's growth potential. However, over the long term, the government ...
$1,295.00
Read More...
Colombia Pharmaceuticals & Healthcare Report

Colombia Pharmaceuticals & Healthcare Report

Pub date:27 Aug 2014

BMI View:   President Juan Manuel Santos' re-election in June has given him a strong mandate to continue the process of healthcare reform in Colombia. Although the Santos administration has been successful in limit ing medicine ...
$1,295.00
Read More...
Showing 1-20 of 180
Sort By